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ABSTRACT
Renal cell carcinoma (RCC) presenting as left supraclavicular lymph node recurrence is rare, even though it can spread to any site 
in the body. There are very few cases of RCC with metastasis to the head and neck areas reported in the literature. Here, we report 
a case of clear cell carcinoma of RCC in a 16-year-old female who presented with the left supraclavicular recurrence after 5 months 
of radical nephrectomy. There were no metastasis foci identified elsewhere in the body. The patient was treated with sorafenib. After 
treatment, the lymph node regressed in size with no significant side effects. Clinicians and pathologists both should be aware of this 
unusual site of presentation during the evaluation of single-site metastasis in RCC.
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Renal cell carcinoma (RCC) has multiple histological subtypes, with different biological behaviour. Approximately, 20 to 40% clinically localised RCC can 
develop metastasis. The 10-year survival rate of metastatic RCC 
is less than 5% [1]. Metastasis to head and neck area is very 
uncommon as it most commonly spread to lung, liver and bone 
[1,2]. RCC presenting with left supraclavicular enlarged lymph 
node postoperatively is very rare and very few cases are reported 
in the literature [2]. Here, we report a case of RCC post-radical 
nephrectomy presenting with left supraclavicular recurrence with 
a review of the literature.
CASE REPORT
A 16-year-old female presented with complaints of mass per 
abdomen of 3-month duration which was gradually increasing 
in size, anorexia, malaise and left flank pain 3-month duration. 
The pain was dull aching, non-radiating and not associated with 
nausea or vomiting. There was no history of haematuria, fever, 
cough, breathlessness, or any other swelling in the body. 
On examination, she had a pulse rate of 68 per minute, 
blood pressure of 114/70mm Hg and pallor was present with 
lymphadenopathy. On per abdomen examination, a mass of 
10x12cm was occupying left lumbar, left hypochondrium and 
umbilical area. The mass was non-tender, has smooth surface and 
firm consistency. On bimanual palpation, all the margins were well 
felt except posterior as it was merging with the muscular plane. 
Investigation revealed haemoglobin of 6.2g/dl and other 
blood investigations were normal. The renal function test, 
liver function tests and serum calcium level were normal. 
The chest X-ray was normal. Ultrasound showed ill-defined 
heterogeneous mass arising from the lower pole of the left 
kidney measuring 10x11.5cm size with gross hydronephrosis. 
Contrast-enhanced computed tomography (CECT) showed a 
well-defined arterial phase enhancing mass (85HU) lesion in the 
lower pole of the left kidney. The mass was of 7x7.x10.3cm with 
moderated hydronephrosis with normal left renal vein and with 
no thrombus. No retroperitoneal lymphadenopathy was noted. 
Preoperatively, she was given two units of packed red 
blood cells and underwent the left radical nephrectomy. The 
postoperative period was uneventful and she was discharged on 
day 7. Histopathological examination showed clear cell variant 
of RCC without capsular invasion and no evidence of renal 
pelvis/sinus invasion with the International Society of Urological 
Pathology (ISUP) Grade of 3. Finally, based on the histological 
examination, a diagnosis of left RCC of clear cell variant with 
stage 2 (pT2b No Mo) was given. 
She underwent CECT of abdomen and pelvis at three 
months follow-up and no significant abnormality was detected. 
On the 5th month follow-up, she again presented with swelling 
in the left supraclavicular area. The swelling persisted for 1 
week and gradually increased in size. On examination, a left 
Virchow’s lymph node (LN) was enlarged. The lymph node was 
of 2x2cm in size, non-tender, firm in consistency and mobile. 
Complete hemogram, liver function tests and renal function 
tests were normal. CECT neck and thorax showed an enlarged 
lymph node measuring 18x19mm in the left supraclavicular 
area (Fig. 1). 
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Fine needle aspiration cytology was done which showed 
feature suggestive carcinoma cell resembles metastatic deposits 
of RCC (Fig. 2). CECT of abdomen and pelvis showed no 
significant abnormality. She was treated with tablet sorafenib 
200mg once a day for three months. On subsequent follow-up, 
the left supraclavicular lymph node decreased in size (5x5mm) 
as shown in CECT. 
DISCUSSION
Renal cell carcinoma accounts for 2-3% of all malignancy 
and the second most common urological cancer, with male 
predominance1. Usually, the carcinoma manifest in the 6th or 7th 
decade of life and has bimodal age distribution [1,2]. There are a 
number of different varieties of RCC derived from various parts 
of nephron with unique characteristics and tumour behaviour [2]. 
Clear cell carcinoma of RCC arising from proximal convoluted 
tubule (PCT) accounts for 70-80% subtype and has a worse 
prognosis as compared with papillary or chromophobe type of 
RCC even after stratification for stage and grade [2,3]. 
RCC most commonly metastasize through hematogenous 
route to lung (45%), bone (30%), lymph node (22%), liver (20%), 
adrenal gland (9%) and it is very uncommon for RCC to present 
as neck lymph node [1]. The exact mechanism of metastasis 
to the left supraclavicular lymph node is not understood [4]. 
Metastasis can occur through Batson’s paraspinal plexus which 
is valveless anastomosis network with minimal resistance to 
tumour emboli. Through this venous plexus by bypassing the 
pulmonary venous system, metastasis can occur in head and 
neck area [4,5].
There are several case reports of RCC metastasis to the 
head and neck area. Kannappa LK et al. reported a rare case of 
sarcomatoid RCC manifesting with supraclavicular lymph node 
metastasis [6]. Bouadel N et al. also reported cervical lymph 
node metastasis in chromophobe RCC [7]. Metastatic RCC 
in a supraclavicular lymph node with no known primary was 
reported by Young-Rak Choi et al8. Metastatic cutaneous head 
and neck RCC with no known primary reported by Bhatia S 
et al [9]. Elfadaly A et al reported a case of metastatic clear 
cell RCC with unknown primary in a living donor kidney 
transplant recipient in a 68-year-old patient who presented with 
supraclavicular, mediastinal and retroperitoneal lymph node 
involvement [10].
The metastasis usually involves a single-site and should 
be treated aggressively with local therapy, radiotherapy and 
systemic therapy because multimodal treatment can have 
a long-term disease-free survival rate. In our case, it was a 
single-site metastasis which was identified through histological 
examination and CECT. The patient in our case was started 
on sorafenib which is an oral receptor kinase inhibitor with 
activity against vascular endothelial growth factor receptor-2 
(VEGFR-2), platelet-derived growth factor receptor-β 
(PDGFR-β), and rapidly accelerated fibrosarcoma-1 (raf-1) 
(200mg Once a day) [9]. Reported side effects of sorafenib are 
hypertension, fatigue, rash, hand-foot syndrome, and diarrhoea 
[11,12]. Our patient responded very well for this medicine but 
had facial rashes and loss of appetite.
CONCLUSION
Renal cell carcinoma presenting as head and neck metastasis 
is a very unusual presentation but the clinician and pathologist 
should consider the possibilities of metastasis as a number ofcase 
reportspresent in the literature reported about the metastasis of 
RCC to the head and neck.In our case, the patient has responded 
well with systemic therapy but if any relapse or progression 
occurs, the patient should be subjected to radiotherapy 
and/or surgery. 
Figure 1: CECT showing enlarged left supraclavicular lymph 
node.
Figure 2: Fine needle aspiration from the left supraclavicular lymph 
node showing metastatic deposit from the renal cell carcinoma.
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